LBP-EC01 is a bacteriophage ‘cocktail’ that has been modified using CRISPR/Cas3 gene-editing to improve its ability to target the E coli genome. Lab studies have demonstrated it is ...
Hosted on MSN7mon
Phage display technology effectively improves specific targeting ability of anti-microbial peptides against S. aureusPhage display technology involves the fusion ... Subsequently, to investigate the targeting ability of SFK2, S. aureus ATCC 6538 and E. coli ATCC 25922 were mixed 1:1, treated with 8 μM SFK2 ...
Live Science on MSN3mon
'Medicine needed an alternative': How the 'phage whisperer' aims to replace antibiotics with virusesOne alternative to antibiotics is phage therapy, which harnesses viruses ... Biswas's days revolved around injecting mice ...
Like people, bacteria get invaded by viruses. In bacteria, the viral invaders are called bacteriophages, derived from the ...
Their potential as antibacterial agents was appreciated almost immediately, with the first 'phage therapy' trials predating Fleming's discovery of penicillin by approximately a decade. In this ...
Scientists have sought to learn how the single-cell organisms survive phage infection in a bid to ... including Staph and E. coli infections and cholera, become toxic to humans - a process that ...
“E. coli is a bug that we all have in our intestines ... There is hope in the fight against pathogens, which has seen a lot of activity around phage-based interventions.
Future Microbiol. 2013;8(6):769-783. The use of phage cocktails can be conceptually differentiated into: efforts that seek to broaden the utility of phage formulations, that is, what diseases or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback